Anterogen Is A Bio Venture Company Specializing In Research And Development Of Cell Therapy Products And Orphan Drugs Using Adult Stem Cellsestablished A Research Institute In Boston In 2000Anterogen Began Commercializing Products Using Adipose Derived Stem Cells For The First Time In Korea In January 2012We Obtained A Market Authorization Of Cupistemainjection As An Adipose Derived Stem Cell Therapy Product For The First Time In The World Anterogenan Emerging Global Leader In The Field Of Cell Therapy Productshas Developed Adipocella For The Treatment Of Depressed Scar Queencella For The Regeneration Of Subcutaneous Adipose Tissueand Cupistemainjectionfor The Treatment Of Crohn S Fistulawith Accumulated Experiences And R&D Technology In Stem Cell Therapy
